Articles from GlobeNewswire

Stellantis and Mistral AI Strengthen Strategic Partnership to Enhance Customer Experience, Vehicle Development and Manufacturing

Hydro's fourth quarter results 2024 will be released at 07:00 CET (01:00 EST, 06:00 UTC/GMT) on February 14, 2025. The annual report 2024 will be released the same day at 08:00 CET (02:00 EST, 07:00 UTC/GMT). The quarterly report, presentation slides and annual report will be available on hydro.com at the same time as the releases.  

ROCKVILLE, Md., Feb. 07, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it will release financial results for the fourth quarter and full year 2024 after the U.S. market close on Tuesday, March 11th, 2025. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time.

The following is an extract from the “Iveco Group 2024 Full Year and Fourth Quarter Results (*). The complete press release can be accessed by visiting the media section of the Iveco Group corporate website: https://www.ivecogroup.com/media/corporate_press_releases or consulting the accompanying PDF:

Execution of a share buyback agreement for up to €2 billion

Summerfield, a four-hour 240 MW / 960 MWh battery energy storage system, is expected to be operational in 2027

NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Methode Electronics Inc. (NYSEMEI) on behalf of long-term stockholders following a class action complaint that was filed against Methode Electronics on August 26, 2024 with a Class Period from December 2, 2021 to March 6, 2024. Our investigation concerns whether the board of directors of Methode Electronics have breached their fiduciary duties to the company.

NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Smith & Wesson Brands, Inc. (NASDAQSWBI) on behalf of long-term stockholders. Our investigation concerns whether the board of directors of Smith & Wesson have breached their fiduciary duties to the company.

NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against ZoomInfo Technologies Inc. (NASDAQZI) on behalf of long-term stockholders following a class action complaint that was filed against ZoomInfo on September 4, 2024 with a Class Period from November 10, 2020, and August 5, 2024. Our investigation concerns whether the board of directors of ZoomInfo have breached their fiduciary duties to the company.

NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Monolithic Power Systems, Inc. (“Monolithic Power Systems” or the “Company”) (NASDAQMPWR) in the United States District Court for the Western District of Washington on behalf of all persons and entities who purchased or otherwise acquired Monolithic Power Systems securities between February 8, 2024 and November 8, 2024, both dates inclusive (the “Class Period”). Investors have until April 7, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) --

PRINCETON JUNCTION, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of MISTRAS Group, Inc. (NYSEMG) is deeply saddened to announce the passing of Dr. Sotirios J. Vahaviolos, the company’s Founder, Chairman Emeritus, and Board Director, on Thursday, February 6, 2025.

BOSTON, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, today announced the pricing of its upsized initial public offering of 10,588,233 shares of its common stock at a public offering price of $18.00 per share. In addition, Sionna has granted the underwriters a 30-day option to purchase up to 1,588,234 additional shares of its common stock at the public offering price, less underwriting discounts and commissions. Sionna’s shares are scheduled to begin trading on the Nasdaq Global Market on February 7, 2025 under the ticker symbol "SION." The offering is expected to close on February 10, 2025, subject to the satisfaction of customary closing conditions. All shares of common stock are being offered by Sionna.

SAN DIEGO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all purchasers of the American Depository Receipts ("ADRs") of GSK PLC (NYSEGSK) between February 5, 2020 and August 14, 2022. GSK is a global pharmaceutical company that develops, manufactures, and markets vaccines and medicines worldwide.

SAN DIEGO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all purchasers of Monolithic Power Systems Inc. (NASDAQMPWR) common stock between February 8, 2024 and November 8, 2024. Monolithic is a provider of power management components used in electronic systems.

Fiscal 2025 First Quarter Financial Highlights:

Honoring the Legacy of Peter Drucker and the Contributions of Distinguished Faculty

LISLE, Ill., Feb. 06, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of CTS Corporation (NYSECTS) has declared a cash dividend of $0.04 per share on outstanding shares of common stock, without par value, to be paid on April 25, 2025, to shareholders of record at the close of business on March 28, 2025.

Project Reaches Key Milestone towards Commercial Production

An Officer prevented tragedy last month at an Arizona east side school

NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) --

TORONTO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- McEwen Mining Inc. (NYSEMUX) (TSX: MUX) (the “Company”) today announced its intention to offer, subject to market conditions and other factors, $85 million aggregate principal amount of convertible senior notes due 2030 (the “Notes”) in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the offering, the Company expects to grant to the initial purchaser of the Notes an option to purchase, for settlement within a 13-day period from the date of initial issuance of the Notes, up to an additional $15 million aggregate principal amount of Notes.

BERKELEY HEIGHTS, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Viventium, the leading SaaS-based human capital management platform serving the healthcare industry, has earned second place in the Multimedia Campaign category for Home Health & Home Care (Vendor) at the 2025 Aspect Awards. The award recognizes the 2024 Caregiver Onboarding Experience Report: A Re-Think is Overdue, a proprietary research initiative that brings much-needed attention to critical workforce challenges in home-, facility-, and community-based care.

SET-JETTING: STAY IN MOVIE-STAR HOTELS WITH ALL.COM

LOS ANGELES, Feb. 06, 2025 (GLOBE NEWSWIRE) -- WEBTOON Entertainment Inc. (Nasdaq: WBTN) (“WEBTOON Entertainment,” or “the Company”), a leading global entertainment company and home to some of the world’s largest storytelling platforms, today announced select preliminary, estimated and unaudited results for its fourth quarter and full year 2024 ended December 31, 2024 ahead of parent company, NAVER Corporation’s earnings release today.

MINNEAPOLIS, Feb. 06, 2025 (GLOBE NEWSWIRE) -- 75F, a leader in IoT and AI-driven commercial HVAC automation, today announced a $45M Series B funding round, one of the largest in Minnesota history. This investment, led by Accurant International's Net Zero Alliance, with participation from Carrier Global Corporation, Climate Investment, Breakthrough Energy Ventures, Next47, and WIND Ventures, underscores the market’s growing confidence in light commercial building automation and 75F's easy and cost-competitive approach to building energy efficiency.

ST. JOHN'S, Newfoundland and Labrador, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Fortis Inc. ("Fortis" or the "Corporation") (TSX/NYSE: FTS) will release its 2024 financial results on Friday, February 14, 2025. A teleconference and webcast will be held the same day at 8:30 a.m. (Eastern). David Hutchens, President and Chief Executive Officer and Jocelyn Perry, Executive Vice President and Chief Financial Officer will discuss the Corporation's 2024 annual financial results.

SAN DIEGO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report fourth quarter and full year 2024 financial results on Thursday, February 27, 2025 after the market closes. Company management will host a conference call at 4:30 p.m. ET to discuss financial results and provide a business update.

PURCHASE, NY, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSETDOC), the global leader in virtual care, today announced that it issued inducement awards to two new employees.

JIAXING, CHINA, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Huachen AI Parking Management Technology Holding Co., Ltd (the "Company") (NASDAQHCAI), a comprehensive smart parking solutions and equipment structural parts provider with all operations through the operating subsidiaries in China, today announced the closing of its initial public offering (the "Offering") of 1,500,000 ordinary shares, par value $0.00000125 (the "Ordinary Shares") at a public offering price of $4.00 per share for total gross proceeds of $6.0 million before deducting underwriting discounts and offering expenses. The Ordinary Shares began trading on the Nasdaq Capital Market on February 5, 2025 under the ticker symbol “HCAI.”

NOVATO, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQRARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultrarare genetic diseases, today announced that it will host a conference call at 5:00 p.m. ET on Thursday, February 13, 2025, to discuss its financial results and corporate update for the quarter and the year ending December 31, 2024.

Topline data from Phase 3 ONWARD trials for Alumis’ ESK-001 in moderate-to-severe plaque psoriasis on track for readout in first half of 2026; Topline data from Phase 2b LUMUS trial in systemic lupus erythematosus on track for readout in 2026

FAIRPORT, N.Y., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Seneca Foods Corporation (NASDAQ: SENEA, SENEB) today announced financial results for the third quarter and nine months ended December 28, 2024.

WEST DES MOINES, Iowa, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Apollo (NYSEAPO) and Athene Holding Ltd. (“Athene”), today announced that former U.S. Senator Joseph Manchin III has been named an adviser to Apollo and appointed to the Athene Board of Directors, effective February 3, 2025. Senator Manchin will provide advisory services to Apollo on various matters including energy markets, given the firm’s leading role in providing capital to enable the global industrial renaissance.

- Q1 Sales increase 13% to $247 Million - Q1 GAAP EPS increases 54% to $0.91 - Q1 Adjusted EPS as defined in prior guidance increases 48% to $0.92 - Q1 Adjusted EPS excluding Acquisition Related Amortization increases 41% to $1.07 -

OMAHA, Neb., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Greystone Housing Impact Investors LP (NYSEGHI) (the “Partnership”) announced today that it will host a conference call for investors on Thursday, February 20, 2025 at 4:30 p.m. Eastern Time to discuss the Partnership’s Fourth Quarter 2024 results.

Call Scheduled for 4:00 PM ET on Monday, February 10, 2025

JACKSONVILLE, Fla., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Regency Centers Corporation (“Regency Centers”, “Regency” or the “Company”) (Nasdaq: REG) today reported financial and operating results for the period ended December 31, 2024 and provided initial 2025 earnings guidance. For the three months ended December 31, 2024 and 2023, Net Income Attributable to Common Shareholders was $0.46 per diluted share and $0.47 per diluted share, respectively. For the twelve months ended December 31, 2024 and 2023, Net Income Attributable to Common Shareholders was $2.11 per diluted share and $2.04 per diluted share, respectively.

Second quarter fiscal 2025 net sales of $90 millionSecond quarter fiscal 2025 gross margin increase of 270 basis points year-over-year to 43.1%Reported second quarter net income of $210,000 and improved adjusted EBITDA1 of $5.9 million

PONTE VEDRA, Fla., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced that it will release financial results for the fourth quarter and full year of 2024 after the close of trading on Thursday, February 27, 2025. Company management will host a conference call to discuss financial results beginning at 4:30 pm ET.

HOUSTON, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The board of directors of APA Corporation (Nasdaq: APA) has declared a regular cash dividend on the company's common shares.

SCOTTSDALE, Ariz., Feb. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQLFST), one of the nation’s largest providers of outpatient mental health care, will issue its fourth quarter and full year 2024 earnings release before the market opens on Thursday, February 27, 2025.

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), February 6, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today outlines the design of new clinical trials within its Acute on-Chronic Liver Failure (ACLF) pipeline, with several clinical data readouts by end of 2025.

CALHOUN, Ga., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Mohawk Industries, Inc. (NYSEMHK) today announced fourth quarter 2024 net earnings of $93 million and earnings per share (“EPS”) of $1.48; adjusted net earnings were $123 million, and adjusted EPS was $1.95. Net sales for the fourth quarter of 2024 were $2.6 billion, an increase of 1.0% as reported and a decrease of 1.0% on an adjusted basis versus the prior year. During the fourth quarter of 2023, the Company reported net sales of $2.6 billion, net earnings of $140 million and earnings per share of $2.18; adjusted net earnings were $125 million, and adjusted EPS was $1.96.

CHARLOTTE, N.C., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Coca-Cola Consolidated, Inc. (NASDAQCOKE) will issue a news release after the market closes on February 20, 2025 to announce its operating results for the fourth quarter and fiscal year ended December 31, 2024.

TORONTO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to announce that it has signed an advisory agreement with Mr. Matthew Azrieli. Mr. Azrieli is a current shareholder of PharmAla Biotech.

CINCINNATI, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation’s largest owners and operators of high-quality, grocery-anchored neighborhood shopping centers, today reported financial and operating results for the fourth quarter and full year ended December 31, 2024 and provided guidance for 2025. For the fourth quarter and full year ended December 31, 2024, net income attributable to stockholders was $18.1 million, or $0.15 per diluted share, and $62.7 million, or $0.51 per diluted share, respectively.

Fourth Quarter 2024 Highlights

SCHAUMBURG, Ill., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Paylocity Holding Corporation (Nasdaq: PCTY), a leading provider of cloud-based HR, payroll, and spend management software solutions, today announced financial results for the second quarter of fiscal year 2025, which ended December 31, 2024.

Q2’25 Financial Results and Recent Business Highlights

OKLAHOMA CITY, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Expand Energy Corporation (NASDAQEXE) announced today that it will release its 2024 fourth quarter and full year operational and financial results after market close on February 26, 2025. A conference call to discuss the results and 2025 plan has been scheduled for February 27, 2025 at 9:00 a.m. EST. Participants can view the live webcast here. Participants who would like to ask a question, can register here, and will receive the dial-in info and a unique PIN to join the call. Links to the conference call will be provided on Expand Energy’s website. A replay will be available on the website following the call.

MENLO PARK, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth quarter and fiscal year 2024 ended January 3, 2025.

LOUISVILLE, Ky., Feb. 06, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQBTSG) announced today that it plans to release its fourth quarter and full year 2024 financial results on Thursday, March 6, 2025, prior to the Company’s earnings conference call, which will be held at 8:30 a.m. ET on the same day.

BOSTON, Feb. 06, 2025 (GLOBE NEWSWIRE) -- CarGurus, Inc. (Nasdaq: CARG), the No. 1 visited digital auto platform for shopping, buying, and selling new and used vehicles1, announced it will issue a press release reporting financial results for the fourth quarter and fiscal year ended December 31, 2024, after the close of the market on February 20, 2025.

SAN JOSE, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQNTNX), a leader in hybrid multicloud computing, today announced that it will report its financial results for the second quarter of fiscal year 2025, which ended January 31, 2025, after U.S. markets close on Wednesday, February 26, 2025.

CAMBRIDGE, Mass., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that management will participate in a fireside chat at the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025 at 1:20 pm ET.

FREMONT, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- ACM Research, Inc. (“ACM”) (NASDAQACMR) announced today that it will release its financial results for the fourth quarter and fiscal year 2024 before the U.S. market open on Wednesday, February 26, 2025. ACM will conduct a corresponding conference call at 8:00 a.m. U.S. Eastern Time (9:00 p.m. China Time) to discuss the results.

MENLO PARK, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has raised its quarterly cash dividend from $0.28 to $0.30 per share of common stock. The quarterly cash dividend of $0.30 per share of common stock is to be paid on March 21, 2025 to all common stockholders of record as of March 7, 2025.

SAN FRANCISCO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQIRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the fourth quarter and full year 2024 after the close of trading on Thursday, February 20, 2025. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.

WASHINGTON, Feb. 06, 2025 (GLOBE NEWSWIRE) -- IBEX Limited (“ibex”), a leading provider in global business process outsourcing and end-to-end customer engagement technology solutions, today announced financial results for its second fiscal quarter ended December 31, 2024.

SAN FRANCISCO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 163,650 shares of the Company’s common stock to seven new employees (the “Inducement Grants”) on January 31, 2025 (the “Grant Date”). The Inducement Grants have been granted pursuant to the Company’s 2023 Inducement Plan (the “Plan”). The Inducement Grants were granted as an inducement material to these individuals entering into employment with 89bio in accordance with Nasdaq Listing Rule 5635(c)(4).

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced its participation at three investor conferences during the first quarter of 2025. MannKind’s Chief Executive Officer Michael Castagna, PharmD, and Chief Financial Officer Chris Prentiss will share updates during the following investor conferences:

ALBUQUERQUE, N.M., Feb. 06, 2025 (GLOBE NEWSWIRE) -- ARRAY Technologies, Inc. (the “Company” or “ARRAY”) (Nasdaq: ARRY) today announced that the company will release its fourth quarter and full year 2024 results after the market close on Thursday, February 27, 2025, to be followed by a conference call at 5:00 p.m. (Eastern Time) on the same day.

KIRKLAND, Wash., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Monolithic Power Systems, Inc. (“MPS”) (Nasdaq: MPWR), a global company that provides high-performance, semiconductor-based power electronics solutions, today announced its Board of Directors has approved a new stock repurchase program that authorizes MPS to repurchase up to $500 million in the aggregate of its common stock, which will expire on February 4, 2028.

EMERYVILLE, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- NMI Holdings, Inc. (Nasdaq: NMIH) today reported net income of $86.2 million, or $1.07 per diluted share, for the fourth quarter ended December 31, 2024, which compares to $92.8 million, or $1.15 per diluted share, for the third quarter ended September 30, 2024 and $83.4 million, or $1.01 per diluted share, for the fourth quarter ended December 31, 2023. Adjusted net income for the quarter was $86.1 million, or $1.07 per diluted share, which compares to $92.8 million, or $1.15 per diluted share, for the third quarter ended September 30, 2024 and $83.4 million, or $1.01 per diluted share, for the fourth quarter ended December 31, 2023.

Gogo Business Aviation (NASDAQGOGO) |Satcom Direct today announced the finalizing of a multifaceted Memorandum of Understanding (MoU) with Airbus.

SAN DIEGO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Newmont Corporation (NYSENEM) securities between February 22, 2024 and October 23, 2024. Newmont is the world’s leading gold mining company and producer of copper, silver, zinc and lead.

SAN DIEGO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Target Corporation (NYSETGT) stock between August 26, 2022 and November 19, 2024. Target Corporation operates general merchandise discount stores in the United States.

Pre-Order Now Available for LaPolt’s Upcoming Book (October 7) and Podcast Launch (Spring 2025)

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Monolithic Power Systems To Contact Him Directly To Discuss Their Options

San Antonio, TX, Feb. 06, 2025 (GLOBE NEWSWIRE) -- U.S. Global Investors, Inc. (Nasdaq: GROW) will host a webcast on Thursday, February 13, at 7:30 a.m. Central time to discuss the company’s results for the second quarter of fiscal year 2025.

Reliable and robust connectivity for industrial automation and harsh environment applications.

Each Unit Includes One Class A Ordinary Share and One Share Right to Receive 1/15th of a Class A Ordinary Share

Macan Electric acknowledged for its performance and design